ReviewPolymers2022
Hybrid Organic-Inorganic Perovskite Halide Materials for Photovoltaics towards Their Commercialization.
Review in Polymers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- First-principles study of lead-free ARSC advances · 2026Article
- A Review of Simulation Tools for Thin-Film Solar Cells.Materials (Basel, Switzerland) · 2024Review
- Performance Enhancement of Hole Transport Layer-Free Carbon-Based CsPbIBrNanomaterials (Basel, Switzerland) · 2024Article
- Patterned Liquid Crystal Polymer Thin Films Improved Energy Conversion Efficiency at High Incident Angles for Photovoltaic Cells.Polymers · 2024Article
- Hybrid Materials: A Metareview.Chemistry of materials : a publication of the American Chemical Society · 2024Review
- Unraveling Degradation Processes and Strategies for Enhancing Reliability in Organic Light-Emitting Diodes.Nanomaterials (Basel, Switzerland) · 2023Review
- Strong exciton-photon coupling in self-hybridized organic-inorganic lead halide perovskite microcavities.Nanophotonics (Berlin, Germany) · 2023Article
- Photocatalytic Properties of ZnO:Al/MAPbI3/Fe2O3 Heterostructure: First-Principles Calculations.International journal of molecular sciences · 2023Article
- Improved Power Conversion Efficiency with Tunable Electronic Structures of the Cation-Engineered [AInternational journal of molecular sciences · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Hybrid organic-inorganic perovskite (HOIP) photovoltaics have emerged as a promising new technology for the next generation of photovoltaics since their first development 10 years ago, and show a high-power conversion efficiency (PCE) of about 29.3%. The power-conversion efficiency of these perovskite photovoltaics depends on the base materials used in their development, and methylammonium lead iodide is generally used as the main component. Perovskite materials have been further explored to increase their efficiency, as they are cheaper and easier to fabricate than silicon photovoltaics, which will lead to better commercialization. Even with these advantages, perovskite photovoltaics have a few drawbacks, such as their stability when in contact with heat and humidity, which pales in comparison to the 25-year stability of silicon, even with improvements are made when exploring new materials. To expand the benefits and address the drawbacks of perovskite photovoltaics, perovskite-silicon tandem photovoltaics have been suggested as a solution in the commercialization of perovskite photovoltaics. This tandem photovoltaic results in an increased PCE value by presenting a better total absorption wavelength for both perovskite and silicon photovoltaics. In this work, we summarized the advances in HOIP photovoltaics in the contact of new material developments, enhanced device fabrication, and innovative approaches to the commercialization of large-scale devices.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.